ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
HiST: Histological Images Reconstruct Tumor Spatial Transcriptomics via MultiScale Fusion Deep Learning.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Spatial transcriptomics (ST) provides valuable insights into the tumor microenvironment by integrating molecular features with spatial context; however, its clinical utility is limited by high costs. To address this, we develop a multi-scale convolutional deep learning framework, HiST, which utilizes ST to learn the relationship between spatially resolved gene expression profiles (GEPs) and histological morphology. HiST accurately predicts tumor regions across multiple cancer types (e.g., breast cancer; area under the curve: 0.96), demonstrating high concordance with pathologist annotations. Moreover, HiST reconstructs spatially resolved GEPs from histological images with an average Pearson correlation coefficient of 0.74 across five cancer types, outperforming existing models by about two-fold. These high-fidelity spatial GEPs enable tumor heterogeneity assessment from histological images, including identification of tumor subtypes with distinct DNA copy number variations. We demonstrate the clinical utility of the predicted GEPs, which robustly stratify patient prognosis across five cancer types from The Cancer Genome Atlas (e.g., breast cancer; concordance index: 0.78). The predicted profiles further facilitate immunotherapy response prediction and enrichment analyses of relevant biological pathways and markers. Collectively, HiST achieves state-of-the-art performance in spatial GEP reconstruction, providing a reliable molecular representation that enhances downstream tasks such as tumor profiling and clinical analyses.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.